Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection-Reference-Cited by-同舟云学术

Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test Selection

Published:2019-04-20 Issue:2 Volume:106 Page:309-312
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Bousman Chad A.¹²³,Zierhut Heather⁴,Müller Daniel J.⁵⁶

Affiliation:

1. Departments of Medical Genetics, Psychiatry, Physiology & PharmacologyUniversity of Calgary Calgary Alberta Canada

2. Alberta Children's Hospital Research Institute Calgary Alberta Canada

3. Mathison Centre for Mental Health Research and EducationHotchkiss Brain InstituteCumming School of MedicineUniversity of Calgary Calgary Alberta Canada

4. Department of Genetics, Cell Biology, and DevelopmentUniversity of Minnesota Minneapolis Minnesota USA

5. Pharmacogenetics Research ClinicCampbell Family Mental Health Research InstituteCentre for Addiction and Mental Health Toronto Ontario Canada

6. Department of PsychiatryUniversity of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1432

Reference4 articles.

1. Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing

2. Recommendations for Clinical CYP2C19 Genotyping Allele Selection

3. Genotype, phenotype, and medication recommendation agreement among commercial pharmacogenetic-based decision support tools

4. PharmGKB.Gene‐specific Information Tables for CYP2D6. Accessed February 12 2019.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis;Translational Psychiatry;2024-07-19

2. Frequencies of CYP2C19 and CYP2D6 gene variants in a German inpatient sample with mood and anxiety disorders;The World Journal of Biological Psychiatry;2024-04-20

3. A Canadian Simulation Model for Major Depressive Disorder: Study Protocol;PharmacoEconomics - Open;2024-03-26

4. Pharmacogenomics to support mental health medication therapy management: Clinical practice considerations and a conceptual framework to enhance patient care;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2023-12-03

5. CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, Australia;Genes;2023-10-16